PMV Pharmaceuticals, Inc.
PMVP
$1.00
$0.000.00%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -7.32% | -14.13% | 7.57% | -2.52% | 0.56% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 4.15% | 18.01% | 36.47% | 4.79% | 38.11% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 0.00% | 0.00% | 0.00% | 0.00% |
Total Current Assets | -7.36% | -13.33% | 8.07% | -2.39% | 1.03% |
|
|||||
Total Current Assets | -7.36% | -13.33% | 8.07% | -2.39% | 1.03% |
Net Property, Plant & Equipment | -91.63% | -0.17% | -2.86% | 0.35% | -1.65% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -2.89% | 32.97% | 0.00% | -4.21% | 5.56% |
Total Assets | -14.41% | -5.91% | 0.28% | -6.06% | -3.40% |
|
|||||
Total Accounts Payable | 218.90% | -54.49% | 427.71% | -73.46% | 92.91% |
Total Accrued Expenses | -27.47% | 79.92% | -44.75% | 3.81% | 9.98% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -71.68% | 7.99% | 30.80% | 3.29% | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 5.95% | 19.13% | -5.58% | -14.05% | 30.92% |
|
|||||
Total Current Liabilities | 5.95% | 19.13% | -5.58% | -14.05% | 30.92% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -93.03% | 1.56% | -2.50% | -2.35% | -2.09% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -40.56% | 10.17% | -4.03% | -8.55% | 13.02% |
|
|||||
Common Stock & APIC | 0.27% | 0.41% | 0.54% | 0.49% | 0.61% |
Retained Earnings | -6.65% | -5.89% | -0.37% | -4.93% | -5.35% |
Treasury Stock & Other | -66.10% | 321.62% | -43.41% | -157.59% | 163.10% |
Total Common Equity | -11.03% | -7.66% | 0.77% | -5.77% | -5.02% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -11.03% | -7.66% | 0.77% | -5.77% | -5.02% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -11.03% | -7.66% | 0.77% | -5.77% | -5.02% |
|